Roser Pujol Selected Research

olaparib

1/2019

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roser Pujol Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 01/2017
6	Fanconi Anemia (Fanconi's Anemia) 01/2022 - 07/2012
5	Chromosome Fragility 01/2019 - 04/2011
3	Hypersensitivity (Allergy) 09/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2018
3	Genomic Instability 01/2018 - 05/2013
1	Complementation Group D1 Fanconi Anemia 09/2021
1	Chromosome Breakage 01/2019
1	Hyperpigmentation 01/2019
1	Microcephaly 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Bloom Syndrome 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Xeroderma Pigmentosum (Kaposi's Disease) 05/2013
1	XFE Progeroid Syndrome 05/2013
1	Bone Marrow Failure Disorders 07/2012

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 04/2011
3	diepoxybutaneIBA 01/2019 - 04/2011
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 07/2012 - 04/2011
1	LigandsIBA 01/2022
1	Transcription Activator-Like Effector NucleasesIBA 01/2020
1	olaparibIBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019
1	Mitochondrial DNA (mtDNA)IBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2018
1	Complementary DNA (cDNA)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	EndonucleasesIBA 05/2013

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 09/2021 - 01/2018